CCL19 and neoplasm: Recently, CCL19/21 have been shown to induce the migration of CD4+ T cells to non-lymphoid tissue, especially to the nervous system [60, 61], to preserve the balance between immune surveillance (against tumor and pathogens) and tolerance.